In 2005, our centre changed its guidelines to initiate HAART concurrently with TB treatment if the CD4 count was <100 cells/mm3 and to delay treatment of HIV for eight weeks if the CD4 count was 101 to 200 cells/mm3. This evidence concerns the gene CD4 and tuberculosis.